Mike Eterman

3PUBLICATIONS
49CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Sep 10, 2026
PLA2G2D in tumour-draining lymph nodes regulates anti-tumour immunity.

|Aug 31, 2026
Neutralizing the IL-12/IL-23 p40 subunit prevents immune checkpoint blockade toxicity without compromising antitumor efficacy.

|May 19, 2023
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance.

Mandy van Gulijk, Anneloes van Krimpen, Sjoerd Schetters

Pageof 1

Frequent Collaborators

3 joint publications

Ralph Stadhouders

2 joint publications

Anneloes van Krimpen

2 joint publications

Joachim G J V Aerts

2 joint publications

Floris Dammeijer

2 joint publications

Nina Rozendaal

2 joint publications

Louis Boon

1 joint publications

Mandy van Gulijk

1 joint publications

Sjoerd Schetters

1 joint publications

Joanne Mankor

1 joint publications

Larissa Klaase

Frequent Collaborators

3 joint publications

Ralph Stadhouders

2 joint publications

Anneloes van Krimpen

2 joint publications

Joachim G J V Aerts

2 joint publications

Floris Dammeijer

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us